Amphoterin includes a sequence motif which is homologous to the Alzheimer's β-amyloid peptide (Aβ), forms amyloid fibrils in vitro, and binds avidly to Aβ

被引:26
|
作者
Kallijärvi, J
Haltia, M
Baumann, MH
机构
[1] Univ Helsinki, Prot Chem Unit, Inst Biomed, Biomedicum Helsinki, FIN-00014 Helsinki, Finland
[2] Univ Helsinki, Haartman Inst, Dept Pathol, FIN-00014 Helsinki, Finland
关键词
D O I
10.1021/bi002095n
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Many of the proteins associated with amyloidoses have been found to share structural and sequence similarities, which are believed to be responsible for their capability to form amyloid fibrils. Interestingly, some proteins seem to be able to form amyloid-like fibrils although they are not associated with amyloidoses. This indicates that the ability to form amyloid fibrils may be a general property of a greater number of proteins not associated with these diseases. In the present work, we have searched for amyloidogenic consensus sequences in two current protein/peptide databases and show that many proteins share structures which can be predicted to form amyloid. One of these potentially amyloidogenic proteins is amphoterin (also known as HMG-1), involved in neuronal development and a ligand for the receptor for advanced glycation end products (RAGE). It contains an amyloidogenic peptide fragment which is highly homologous to the Alzheimer's amyloid beta -peptide. If enzymatically released from the native protein, it forms amyloid-like fibrils which are visible in electron microscopy, exhibit apple green birefringence under polarized light after Congo red staining, and increases thioflavin T fluorescence. This fragment also shows high affinity to A beta as a free peptide or while part of the native protein. Our results support the hypothesis that the potential to form amyloid is a common characteristic of a number of proteins, independent of their relation to amyloidoses, and that this potential can be predicted based on the physicochemical properties of these proteins.
引用
收藏
页码:10032 / 10037
页数:6
相关论文
共 50 条
  • [41] In vitro and in vivo oxidative stress associated with Alzheimer's amyloid β-peptide (1-42)
    Yatin, SM
    Varadarajan, S
    Link, CD
    Butterfield, DA
    NEUROBIOLOGY OF AGING, 1999, 20 (03) : 325 - 330
  • [42] Aggregation and metal-binding properties of mutant forms of the amyloid A beta peptide of Alzheimer's disease
    Clements, A
    Allsop, D
    Walsh, DM
    Williams, CH
    JOURNAL OF NEUROCHEMISTRY, 1996, 66 (02) : 740 - 747
  • [43] Cu(II) binding to monomeric, oligomeric, and fibrillar forms of the Alzheimer's disease amyloid-β peptide
    Karr, Jesse W.
    Szalai, Veronika A.
    BIOCHEMISTRY, 2008, 47 (17) : 5006 - 5016
  • [44] In vitro and in vivo protein oxidation induced by Alzheimer's disease amyloid β-peptide (1-42)
    Butterfield, DA
    Yatin, SM
    Link, CD
    OXIDATIVE/ENERGY METABOLISM IN NEURODEGENERATIVE DISORDERS, 1999, 893 : 265 - 268
  • [45] Stable complexes involving acetylcholinesterase and amyloid-β peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer's fibrils
    Alvarez, A
    Alarcón, R
    Opazo, C
    Campos, EO
    Muñoz, FJ
    Calderón, FH
    Dajas, F
    Gentry, MK
    Doctor, BP
    De Mello, FG
    Inestrosa, NC
    JOURNAL OF NEUROSCIENCE, 1998, 18 (09): : 3213 - 3223
  • [46] Pharmacodynamics in Alzheimer's disease model rats of a bifunctional peptide with the potential to accelerate the degradation and reduce the toxicity of amyloid β-Cu fibrils
    Wang, Dan
    Zhang, Qian
    Hu, Xiaoyu
    Wang, Wei
    Zhu, Xushan
    Yuan, Zhi
    ACTA BIOMATERIALIA, 2018, 65 : 327 - 338
  • [47] Anti-amyloidogenic activity of S-allyl-L-cysteine and its activity to destabilize Alzheimer's β-amyloid fibrils in vitro
    Gupta, Veer Bala
    Rao, K. S. J.
    NEUROSCIENCE LETTERS, 2007, 429 (2-3) : 75 - 80
  • [48] Aluminium, iron, zinc and copper influence the in vitro formation of amyloid fibrils of Aβ42 in a manner which may have consequences for metal chelation therapy in Alzheimer's disease
    House, E
    Collingwood, J
    Khan, A
    Korchazkina, O
    Berthon, G
    Exley, C
    JOURNAL OF ALZHEIMERS DISEASE, 2004, 6 (03) : 291 - 301
  • [49] Sequence-specific recognition of the internalization motif of the Alzheimer's amyloid precursor protein by the X11 PTB domain
    Zhang, ZT
    Lee, CH
    Mandiyan, V
    Borg, JP
    Margolis, B
    Schlessinger, J
    Kuriyan, J
    EMBO JOURNAL, 1997, 16 (20): : 6141 - 6150
  • [50] Immunization with a nontoxic/nonfibrillar amyloid-β homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice
    Sigurdsson, EM
    Scholtzova, H
    Mehta, PD
    Frangione, B
    Wisniewski, T
    AMERICAN JOURNAL OF PATHOLOGY, 2001, 159 (02): : 439 - 447